Form D — ORF Biologics, Inc.

0002048350-26-000004 · filed Jul 31, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $2,500,000
Reported amount sold: $1,734,220
Minimum investment: $0
Investors: 17
Sales commission: $0
Finders' fees: $0

Issuer

Name: ORF Biologics, Inc.
CIK: 2048350
Entity: Corporation
Jurisdiction: IOWA
Year incorporated: 2024
Address: 1110 TALL GRASS DRIVE
TIFFIN, IA 52340
Phone: 3199920004

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Steven Michalicek · Director

Cedar Rapids, IA Find on LinkedIn ↗
Anant Kamath · Executive Officer

Tiffin, IA Find on LinkedIn ↗
Jay Kamath · Executive Officer

Tiffin, IA Find on LinkedIn ↗
Sara Ternes · Executive Officer

Tiffin, IA Find on LinkedIn ↗
Nicholas Taiber · Director

Cedar Falls, IA Find on LinkedIn ↗
Roger A. Baker · Director

Estero, FL Find on LinkedIn ↗
John R. Huiskamp · Director

Cedar Rapids, IA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗